Omada Health, Inc. (OMDA)

Market Cap	738.34M
Revenue (ttm)	260.21M +53.2%
Net Income	-12.78M
EPS	-0.35
Shares Out	58.93M
PE Ratio	n/a
Forward PE	65.81
Dividend	n/a
Ex-Dividend Date	n/a

Volume	580,498
Open	13.00
Previous Close	12.40
Day's Range	12.50 - 13.15
52-Week Range	10.28 - 28.40
Beta	n/a
Analysts	Buy
Price Target	22.70 (+81.17%)
Earnings Date	May 17, 2026

About OMDA

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for emplo...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 6, 2025
• Employees: 916
• Stock Exchange: NASDAQ
• Ticker Symbol: OMDA
• Website: https://www.omadahealth.com

Financial Performance

In 2025, Omada Health's revenue was $260.21 million, an increase of 53.24% compared to the previous year's $169.80 million. Losses were -$12.78 million, -72.89% less than in 2024.

Analyst Summary

According to 10 analysts, the average rating for OMDA stock is "Buy." The 12-month stock price target is $22.7, which is an increase of 81.17% from the latest price.

Price Target

$22.7

(81.17% upside)

Analyst Consensus: Buy